Drug Trial Radar · NCT03969212
Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households
Last checked: Nov 20, 2026Latest source record: Jul 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
4,138
Actual
Start
Oct 10, 2019
Primary completion
May 10, 2024
Study completion May 10, 2024
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- May 31, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 5 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Otherwise healthy index patients (IP) are randomized to either baloxavir marboxil or placebo if their influenza symptoms onset was within 48 hours of screening. Their households are enrolled within 24 hours of randomization if at least 1 household contacts (HHC) have not received influenza vaccine within 6 months of screening and if all HHC screen negative for influenza infection. The main endpoints are assessed based on multiple respiratory swabs, obtained from both IP and HHC up to 9 (+/-1) days post IP randomization, and through the assessment of symptoms.
Conditions
- Influenza
Interventions
Baloxavir MarboxilDrug
IPs less than 12 years old will receive either 2 mg/kg (if weight less than 20 kg) or 40 mg (if weight more than or equal to 20 kg) of Baloxavir Marboxil as oral suspension. IPs more than or equal to 12 years old will receive either 40 mg (if weight less than 80 kg) or 80 mg (if weight more than or equal to 80 kg) of Baloxavir Marboxil as tablets. HHCs of IPs will not receive study medication.
PlaceboDrug
IPs less than 12 years old will receive placebo oral suspension and those above 12 years will receive placebo tablets. HHCs of IPs will not receive study medication.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of HHCs With Virological Influenza Transmission by Day 5Time frame: Baseline (Day 1) to Day 5
Locations
142 sites in 16 countries. Site status is shown where the registry gives one.
Cahaba Research, Inc.
Birmingham, Alabama
Cahaba Research, Inc
Pelham, Alabama
Precision Trials
Phoenix, Arizona
Hope Clinical Research
Canoga Park, California
Long Beach Clinical Trials
Long Beach, California
Downtown LA Research Center
Los Angeles, California
Probe Clinical Research
Riverside, California
MD Strategies Research Centers
San Diego, California
Cherry Creek Family Practice
Denver, Colorado
Proactive Clinical Research, LLC
Fort Lauderdale, Florida
Helios Clinical Research, Inc (former Ventavia Research Group)
Kissimmee, Florida
South Florida Research Center, Inc.
Miami, Florida
Cordova Research Institute, LLC
Miami, Florida
Research Institute of South Florida Inc
Miami, Florida
Kendall South Medical Center Inc.
South Miami, Florida
Agile Clinical Research Trials
Atlanta, Georgia
Clinical Research Prime
Idaho Falls, Idaho
Mishawaka Osteopathic Clinic
Mishawaka, Indiana
Washington University School of Medicine
St Louis, Missouri
Mercury Street Medical Group
Butte, Montana
Montana Medical Research LLC
Missoula, Montana
Accent Clinical Trials
Las Vegas, Nevada
Excel Clinical Research
Las Vegas, Nevada
OnSite Clinical Solutions LLC
Charlotte, North Carolina
Burke Primary Care
Morganton, North Carolina
Hometown Urgent Care and Occupational Health - Springdale
Cincinnati, Ohio
Tristar Clinical Investigations
Philadelphia, Pennsylvania
Frontier Clinical Research
Scottdale, Pennsylvania
Frontier Clinical Research
Smithfield, Pennsylvania
Frontier Clinical Research
Smithfield, Pennsylvania
Jedda Enterprises dba Galen Clinical Research
Greer, South Carolina
AFC Urgent Care-Gunbarrell
Chattanooga, Tennessee
Helios Clinical Research, Inc (former Ventavia Research Group)
Jackson, Tennessee
City Doc Urgent Care-Dallas/Ft. Worth
Dallas, Texas
Southwest Family Medicine Associates
Dallas, Texas
Premier Pulmonary Critical Care and Sleep Medicine
Denison, Texas
Pioneer Research Solutions
Houston, Texas
Vilo Research Group
Houston, Texas
Fairway Medical Clinic
Houston, Texas
Mercury Clinical Research
Houston, Texas
Showing 40 of 142 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.